[(4S)-4,5-二氢-4-(1-甲基乙基)-2-噁唑基]二茂铁;(
S
)-(4-异丙基恶唑啉-2-基)二茂铁;[(4S)-4,5-二氢-4-异丙基-2-噁唑基]二茂铁;(S)-(4-异丙基恶唑啉-2-基)二茂铁;[(4S)-4,5-二氢-4-(1-甲基乙基)-2-恶唑基]二茂铁;(S)-(4-ISOPROPYLOXAZOLIN-2-YL)FERROCENE (S)-(4-异丙基恶唑啉-2-基)二茂铁;(S)-(4-异丙基噁唑啉-2-基)二茂铁;(S)-(4-异丙基恶唑啉-2-基)二茂铁,>98.0%(GC)(T); (S)-(4-Isopropyloxazolin-2-yl)ferrocene;(S)-(-)-[4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]ferrocene, min. 98%;[(4S)-4,5-dihydro-4-(1-Methylethyl)-2-oxazolyl]-Ferrocene;(
S
)-(4-Isopropyloxazolin-2-yl)ferrocene;[(4S)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]ferrocene,99%e.e.;(S)-(-)-[4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]ferrocene;(S)-(4-Isopropyloxazolin-2-yl)ferrocene>(S)-iPr-Ferrox
(S,S)-[2-(4'-异丙基噁唑啉-2'-基)二茂铁基二苯基膦;(S)[(SP)-2-(二苯基膦)二茂铁基]-4-异丙基噁唑啉;(2S)-1-[(4S)-4,5-二氢-4-(1-甲基乙基)-2-噁唑基]-2-(二苯基膦)二茂铁;(S)-1-(二苯基膦基)-2-[(S)-4-异丙基噁唑啉-2-基]二茂铁;(S)[(SP)-2-(二苯基膦)二茂铁基]-4-异丙基唑啉;(SP)-1-(二苯基膦)-2-[(4S)-4-异丙基-2-唑基]二茂铁;(S,S)-[2-(4-异丙基-2-恶唑啉基)二茂铁基]二苯基膦;(S)[(SP)-2-(二苯基膦)二茂铁基]-4-异丙基噁唑啉 (SP)-1-(二苯基膦)-2-[(4S)-4-异丙基-2-噁唑基]二茂铁; (
S
)-1-(Diphenylphosphino)-2-[(
S
)-4-isopropyloxazolin-2-yl]ferrocene;(S,S)-[2-(4'-i-Propyloxazolin-2'-yl)ferrocenyldiphenylphosphine, min. 97%;(S,S)-[2-(4'-i-Propyloxazolin-2'-yl)ferrocenyldiphenylphosphine;(S,S)-ip-FOXAP;(2S)- 1-[(4S)-4,5-dihydro-4-(1-Methylethyl)-2-oxazolyl]-2-(diphenylphosphino)-Ferrocene;(S,S)-[2-(4-Isopropyl-2-oxazolinyl)ferrocenyl]diphenylphosphine, 97%;(S,S)-[2-(4'-i-Propyloxazolin-2'-yl)ferrocenyldiphenylphosphine,97%;(S)[(Sp)-2-(Diphenylphosphino)ferrocenyl]-4-isopropyloxazoline
